Call for Abstract

16th World Hematology Congress, will be organized around the theme “Advancements and New Outlook in Hematology”

Hematology Congress 2019 is comprised of keynote and speakers sessions on latest cutting edge research designed to offer comprehensive global discussions that address current issues in Hematology Congress 2019

Submit your abstract to any of the mentioned tracks.

Register now for the conference by choosing an appropriate package suitable to you.

Hematology in the sense haematology. The word heme came from Greek which mean blood. hematology is the science which deals with blood and its disorders and blood forming organs and this science includes the diagnosis, treatment, prevention towards diseases related to blood and malignance’s like haemophilia, leukaemia, lymphoma and sickle-cell anaemia. Hematology mainly focused on blood components like blood cells, haemoglobin, blood proteins, bone marrow, spleen and coagulation mechanism.

Hematologists makes sure of blood levels if the levels either highly elevated nor depleted physician go with bone marrow aspiration. Varying or low rates of synthesis in haemoglobin leads to anaemia and also bleeding disorders and failure of coagulation mechanism, polycythaemia a disease condition where we can observe elevation of red blood cells Hematologists treat this state by employing phlebotomy taking the root cause into consideration that is reducing the haematocrit levels all these conditions come under hematopathology.

Physicians who work on treating hematologic disorders, referred to as Hematologists. Some Hematologists also maintains laboratory who were referred hematopathologists they work on to formulate the best diagnosis for treating hematologic disorders, in some cases Hematologists as well hematopathologists both work in conjugation for giving the best therapy.      

  • Anaemia.
  • Blood coagulation mechanism.
  • Polycythaemia.
  • histiocytosis. 
  • Hematologic neoplasms.

Genetic Blood disorder is a state where problem is with blood cells and blood components like white blood cells (WBC), circulating platelets and red blood cells (RBC). Any depletion or damaged platelets cause abnormalities in clot formation. Whereas these red blood cells carry oxygen to tissues play a vital role in organ survival decreased oxygen carrying capacity of RBC leads to some disorders like fatigue, shortness of breath, auto immune haemolytic anaemia and also lack of oxygenated blood to brain. Bone marrow dysfunction is the main cause for low levels of white blood cells in some cases WBC gets destroyed by auto immune disorders there by leading to decreased levels and increasing the sort of infections attack.

Depleted levels of leukocytes is a sign that immune system is not having the capacity to handle infections, chronic inflammation utilises leukocytes faster than they are produced leading to dysfunction of bone marrow ultimately triggering the low levels of WBC.

  • Lymphoma.
  • Myelodysplastic syndrome.
  • Von Willebrand disease.
  • Plasma cell myeloma.
  • Primary thrombocythemia.
  • Haemophilia
  • Sickle Cell Anemia
  • Thalassemia
  • Thrombocytopenia
  • Fibrinolytic Disorder
  • Congenital Neutropenia

 

  • Track 2-1Sickle Cell Anemia
  • Track 2-2Thrombocytopenia
  • Track 2-3Fibrinolytic Disorder
  • Track 2-4Congenital Neutropenia

Blood transfusion is the process of receiving whole blood or blood products into one’s systemic circulation intravenously. Transfusion may include injection of whole blood or components such as red blood cells, white blood cells, plasma, platelets or clotting factors. Blood transfusion is usually done in cases of deficiencies, to increase the oxygen saturation, during accidents or during surgery, to treat hematologic conditions such as severe anaemia, leukaemia, and sickle cell disease. Blood transfusion may also be associated with various complications including infections, immunological disorders such as haemolysis or incompatibilities. Hence a very systematic protocol is followed for blood transfusion which includes processing and testing the donor’s blood for possible infectious disorders, particularly for viruses such as Hepatitis B and C, HIV, and West Nile Virus., compatibility testing and hemovigilance.. The system should include monitoring, identification, reporting, investigation and analysis of adverse events near-misses and reactions related to transfusion and manufacturing. Research and advances in this area of Haematology is hence considered a very important aspect.

  • Febrile reactions.
  • Graft versus Host disease (GVHD).
  • Compatibility testing.
  • Autologous blood.

 

Immunohematology referred to be blood banking. This is the laboratory medicine dealing up with preparing blood components, blood for appropriate selection and transfusion and also components that are compatible for transfusion which is helpful in case of severe blood loss or low blood levels. If the selection and compatibility fail this may directs to harm the kidneys, lungs and might be life threating. Transfusion can be recommended in case of illness, burns, cancer, injury. Individuals get immunized when there are previous transfusions of blood or in case of pregnancy. Red blood cells contain antigens and protein markers on their surfaces, if recipient or donors red blood cells doesn’t contain this antigen the antigen lacking individual will lead to form antibodies which destroys the red blood cells.so what blood banks screens, typing and cross matching are carried out for blood and its components before the transfusions.

If immune system of recipient attacks the donor red blood cells this state know to be haemolytic reaction. sometimes hives and itching can also be observed.

  • Transfusion related acute lung injury (TRALI). 
  • Acute kidney failure.
  • Antibody screening.
  • Gel testing.
  • Pretransfusion testing module.
  • Rh-sensitization.

 

Paediatric haematology is a branch of haematology dealing with the general haematological problems seen in neonates or paediatric patients. Other issues such as blood counts, Polycythaemia, Neonatal anaemia, Anaemia of prematurity, Haemolytic anaemia in the neonate, Congenital red cell defects, acquired red cell defects, Hyperbilirubinemia, Congenital dyserythropoietic anaemia, Acquired red cell aplasia, Neutropenia, leukaemia etc are dealt under Paediatric Haematology. Haematopoiesis is different in paediatric patients and neonates compared to adults. By birth, virtually all bone marrow cavities are actively hematopoietic. In childhood, hematopoiesis moves to central bones (vertebrae, sternum, ribs, pelvis). The red cells of the new-born are macrocytic and the blood film from a new-born infant shows macrocytic normochromic cells, polychromasia, and a few nucleated red blood cells. Even in healthy infants there may be mild anisocytosis and poikilocytosis. Blood viscosity, oxygen delivery, Iron and transferring content, red cell antigens and many other features are different in neonates and children compared to the adults. Hence a thorough research enabling a proper diagnosis and treatment of all the haematological disorders in neonates and paediatric patients is highly necessary.

  • Acanthocytosis.
  • Cancer infection control.
  • Thrombocytopenia in new-born.
  • Systemic disorders.

 

Haematology is a broad concept which deals with topics ranging from haematopoiesis (production of blood cells) to laboratory diagnosis of various diseases through the study of blood. Veterinary Haematology deals with all these aspects of Haematology in animals. Veterinary Haematology is important as there are significant differences in the blood cells of animals from human beings. Mammals have anucleate platelets and erythrocytes while birds and reptiles have nucleus cells. Size of the erythrocytes is also different in different animals. Different mammals have unique responses to inflammation. These differences make the assessment of blood and diagnosis of blood disorders more difficult than mammals, particularly human beings. So study of haematological characteristics of animals is important in diagnosing the disease. In poultry, dairy, meat and other industries involving animals such as sericulture, early diagnosis of these disorders is important in preventing huge financial losses. Veterinary haematology is also important to diagnose, and control infections spread to humans from animals.

  • Erythropoiesis.
  • Hematotoxicity.
  • Haemostasis.
  • Animal case studies and reports.
  • Species specific hematology.

 

  • Track 6-1• Haemostasis

Stem cell research

Stem cell research deals with research and publication of high quality manuscripts related to stem cells. Stem cells are cells of multicellular organisms that can differentiate into other types of cells. They can divide more cells of the same type of stem cells. For a cell to be considered a stem cell, it should be self-renewing and must be either totipotent or pluripotent. Various types of stem cells such as embryonic stem cells, foetal and adult stem cells tissue specific stem cells, haemopoietic stem cells, cancer stem cells are known. Haemopoietic stem cells that give rise to other blood cells by a process called Hemopoiesis in the red bone marrow. Haemopoietic stem cell transplants are used in the treatment of cancers and other immune system disorders.

  • Stem cell therapy.
  • Different types of stem cells.
  • Stem cell transplantation.
  • Stem cell biomarkers.
  • Stem cell products.

 

Initially for detecting the blood disorders bone marrow biopsy will be carried out which involves the study of cytogenetics and surface proteins on bone marrow cells and this study process referred to be flow cytometry. Treating of blood disorder may vary for every particular disorder, this can include use of coagulation factor support, immune modulating therapies, chemotherapy, bone marrow transplantation palliative care must be taken for the patients with complex disorder. Antithrombic are the class of drugs that works in preventing coagulation of blood which can be used in haemodialysis. in preventive measure for life threatening pulmonary emboli cases interventional radiologists implant vena cava filter by the help of ionizing radiation. Generally, through physical examinations, medical reports are used to detect the disorders by physicians to initiate the best therapy.

  • Hemochromatosis.
  • Idiopathic thrombocytopenic purpura.
  • Malaise.
  • Bone marrow transplantation.
  • Blood transfusion.

 

Hematology-oncology is the science applied to treat blood disorders and diseases and(hematology) and cancers (oncology). Also, it treats with blood cancers and some disease include iron deficiency anaemia, thalassemia’s as well other organ cancers. Bone marrow cancers concerns with leukaemia’s in which WBC cancer takes place in this condition bone marrow synthesis other blood cells, initiating to bone tumours state referred to as multiple myeloma in this abnormal protein were created leading kidney dysfunction and can be identified by some symptoms like bone pain, frequent bone breaking and also constipation sometimes, mostly patients with the treatments like chemotherapy, radiation, plasmapheresis. The treatment will vary for individual suffering with myeloma based on many factors, in this multiple myeloma it includes a stage referred smoldering stage in which it doesn’t show active symptoms that is the state in which myeloma cells present in the body were not progressive.

  • Acute lymphoblastic leukaemia.
  • Acute myelogenous leukaemia.
  • Chronic lymphocytic leukaemia.
  • Acute monocytic leukaemia.
  • Hodgkin’s lymphomas.
  • Non-Hodgkin’s lymphomas.

 

Hematopathology or hemopathology concerns with the study of diseases and disorders that are affecting the blood cells, and their synthesis and some other tissues involved in haematopoiesis like spleen, bone marrow and the thymus. This include cell kinetics which detects the characteristic neoplastic haematolymphoid cells, metabolic hematology used to find the abnormalities in haemoglobin, cytoskeletal abnormalities and red blood cell enzyme deficiency and used to screen the characteristic thalassemia’s and also molecular hematopathology this analyses RNA or DNA in monitoring hematologic malignance’s and to quantify the genetic abnormalities.

Morphology of hematopathology performs the blood count and identify cellular morphology in some body fluids and peripheral blood. Treating of diseases like lymphomas and leukaemia come under hematopathology. Physicians who trained to diagnose the diseases of blood are hematopathologists.

  • Hereditary spherocytosis.
  • Metastatic tumours.
  • Thalassemia’s.
  • Aplastic anaemia.

 

Thalassemia known to be an inherited blood disorder which is capable of forming abnormal haemoglobin synthesis. It is suspected to be a genetic disorder inherited by parents, this of two types alpha thalassemia and beta thalassemia this cannot synthesis beta globin, as well thalassemia intermedia which is less severe, the severity depends on no of genes that have been missing Symptoms may vary depending upon the type from mild to severe anaemia, this can lead to tired, pale skin, enlargement of spleen, bone deformities, delayed growth and development and sometimes dark urine in children. Diagnosis include firstly the complete blood count and also genetic tests along with haemoglobin testing. Treatment may vary from the degree of severity and the therapy may include iron chelation, blood transfusions. Iron chelation can be done through deferoxamine, in case of iron overload from transfusions osteoporosis can be a result and spleen become enlarged which needs a surgical removal in emergency.

Initially for detecting the blood disorders bone marrow biopsy will be carried out which involves the study of cytogenetics and surface proteins on bone marrow cells and this study process referred to be flow cytometry. Treating of blood disorder may vary for every particular disorder, this can include use of coagulation factor support, immune modulating therapies, chemotherapy, bone marrow transplantation palliative care must be taken for the patients with complex disorder. Antithrombic are the class of drugs that works in preventing coagulation of blood which can be used in haemodialysis. in preventive measure for life threatening pulmonary emboli cases interventional radiologists implant vena cava filter by the help of ionizing radiation. Generally, through physical examinations, medical reports are used to detect the disorders by physicians to initiate the best therapy.

  • Hemochromatosis.
  • Idiopathic thrombocytopenic purpura.
  • Malaise.
  • Bone marrow transplantation.
  • Blood transfusion.

 

Polymerase chain reaction (PCR) is a technique used in molecular biology to amplify a single or a few copies of a segment of DNA across several orders of magnitude, generating many copies of a particular DNA sequence. PCR has rapidly become an invaluable technique for the detection and clinical management of a wide variety of haematological disorders. It provides a rapid method for the generation of large quantities of relatively pure DNA sequences of interest. This facilitates nucleotide sequence analysis in both normal and pathological haemopoietic populations. It also aids in the characterisation of normal molecular organisation and of inherited and acquired genetic defects. The extreme sensitivity of detection of rare genetic events has greatly improved the ability to detect minimal residual malignancy and low levels of viral infection.  PCR is more advanced in that genetically modifies abnormal cells can be detected within a normal cell population at far low incidence level than any other existing technology. Advancements in PCR help in Detection of Mutated Genes, Detection of Chromosomal Translocations, Detection of Gene Expression, Detection of Clonality and sequencing.

  • Oncogenes.
  • Preleukemic states.
  • Chromosomal translocations.
  • Real-time polymerase chain reaction.
  • Invasive pulmonary fungal infections.

 

A blood product is a substance prepared from blood used for therapeutic purpose. Blood products include blood components such as red blood cell concentrates, platelets, plasma and cryoprecipitate or plasma derivatives such as albumin, coagulation factor concentrates, immunoglobulins etc. These products are very essential in medical conditions such as anaemia, blood loss, trauma, anaemia, leukaemia etc. Artificial blood or blood surrogate is an artificial substance used to mimic and fulfil some functions of biological blood.  Artificial blood and volume expanders are artificial products and hence research into these products is the need of the hour as they are very essential during emergencies when blood donors are not available. Hence a promising research into the blood products is needed.

  • Pathogen reduction techniques.
  • Artificial blood.
  • Bio-engineered red blood cell products.
  • Therapeutic biological products.
  • Oral anticoagulants.

 

Haematology nursing is a different aspect in nursing where assistance and care for patients with blood diseases and disorders is dealt with. Haematology nurses may also assist in blood tests, transfusions, chemotherapy and other diagnostic and treatments related to blood such as leukaemia, lymphoma, sickle cell anaemia, Hodgkin’s disease and haemophilia. A haematology nurse has responsibilities very similar to an oncology nurse. Haematology nurses involve in both direct and indirect patient care. Direct care involves diagnostic and treatment aspects. Indirect patient care involves information collection and record keeping. Special training is required for Haematology nursing. This training is essential for dealing with sensitive issues such as IV infusions, catheter insertion etc.

  • Hematology nursing products.
  • Paediatric hematology products.
  • Clinical hematology nursing.
  • Blood cancer pain management.
  • Surgical hematology nursing.

 

Biomarkers in hematology were mostly of protein biomarkers which are helpful to detect the tumours early location and mainly to identify bosom growth, these biomarkers simply used to measure and indicate the severity level of disease state. Where as these haematological biomarkers are helpful in identifying the blood disease. Patients who are suspected with pancreatic malignancy will face CT sweep. Recolors neoplastic pancreatic cells will empower the certainty to identify pancreatic tumour by pathologist and hence suitable for treating disease condition. For pancreatic disease a novel drug discovery in biomarkers like BI-010 and IHC markers are developed.

  • Drug Targeting.
  • Prognosis and treatment production.
  • Pharmacodynamics and Pharmacokinetics.
  • Monitoring treatment response.

 

Advancing novel therapeutic agents for the treatment of malignancy into the marketplace is an increasingly costly and lengthy process. As such, new strategies for drug discovery are needed. Drug repurposing represents an opportunity to rapidly advance new therapeutic strategies into clinical trials at a relatively low cost. Known on-patent or off-patent drugs with unrecognized anticancer activity can be rapidly advanced into clinical testing for this new indication by leveraging their known pharmacology, pharmacokinetics, and toxicology. Using this approach, academic groups can participate in the drug discovery field and smaller biotechnology companies can “de-risk” early-stage drug discovery projects. Here, several scientific approaches used to identify drug repurposing opportunities are highlighted, with a focus on hematologic malignancies. In addition, a discussion of the regulatory issues that are unique to drug repurposing and how they impact developing old drugs for new indications is included. Finally, the mechanisms to enhance drug repurposing through increased collaborations between academia, industry, and non-profit charitable organizations are discussed.
·        Hematopoietic Cells Mobilization
·        Patient-reported outcomes in drug development
·        De novo drug discovery
·        Drug Repurposing
·        Clinical trials
·        Future directions and conclusions

 

Vascular haemorrhage ailments upshot from flaws in blood vessels, naturally triggering petechiae, purpura, and bruising nevertheless, excluding for genetic haemorrhagic telangiectasia, rarely top to serious blood injury. Haemorrhage may be the result of deficits of vascular and perivascular collagen in Ehlers-Danlos syndrome besides in other erratic transmissible connective tissue complaints such as pseudoxanthoma elasticum, Marfan syndrome, osteogenesis imperfecta. Bleeding may be a projecting feature of scurvy, or immunoglobulin A–associated vasculitis, a hypersensitivity vasculitis mutual all through juvenile.

  • Track 17-1Atherosclerosis
  • Track 17-2Aneurysm
  • Track 17-3Purpura Simplex
  • Track 17-4Senile Purpura
  • Track 17-5Genetic Hemorrhagic Telangiectasia
  • Track 17-6Hypertension

Hemochromatosis is a disease where excess iron is accumulated in the body by any cause. Commonly affected organs by hemochromatosis are heart, endocrine glands and liver. It can be diagnosed by Ferritin test, Liver function test, Iron test, UIBC, TIBC and Transferrin test. Hemochromatosis may present with the following clinical syndromes: Liver Cirrhosis, Arthritis, Testicular Failure, Joint and bone pain and Cardiomyopathy.

  • Congenital atransferrinaemia 
  • Acaeruloplasminaemia 
  • GRACILE syndrome 
  • Neonatal haemochromatosis
  • Classical haemochromatosis

The theme of hematologic ailment is massive, counting disorders of cellular component extremes, insufficiencies or ruin, and dysfunction. Most of the ailments may lead to neurologic impediment. Some of these conditions are very specific to the hematologic complaint Anemia whereas others are common to numerous circumstances like hyperviscosity syndrome perceived with macroglobulinemia and leukemias. This session deals with Hematologic and their associated neurologic disorders.

 

 

  • Track 19-1sickle Cell Anemia
  • Track 19-2Cerebra Venous Thrombosis
  • Track 19-3Polyneuropathy associates with leukoencephalopathy
  • Track 19-4Thrombocytopenia
  • Track 19-5Thalassemia with paraplegia
  • Track 19-6Hypercoagubility and ischemic stroke
  • Track 19-7Ovarian Hyperstimulation Syndrome
  • Track 19-8Leptomeningeal metastasis
  • Track 19-9Leptomeningeal metastasis
  • Track 19-10APLA syndrome